A rare case report of disseminated Talaromyces marneffei infection presenting as acute pancreatitis in an HIV-1 infected patient Authors: Yanqi Peng, Mi Zhang, Dandan Yang, Yuanlu Shu, Jincheng Lou, Hongli Fan, Zhenglun Li, Suyun Lei, Xingqi Dong, Li Gao Published: 2025 ABSTRACT AbstractBackgroundTalaromyces marneffei (TM) is a thermally dimorphic fungus endemic to Southeast Asia and a major opportunistic pathogen in HIV-1/AIDS patients. We report a rare case of disseminated TM infection presenting with yeast-like fungal structures on peripheral blood smear and complicated by acute pancreatitis.Case PresentationA 52-year-old man with AIDS (CD4+ count: 134 cells/μL) presented with prolonged fever, cough, and weight loss. Peripheral blood smear revealed numerous yeast-like fungal structures. Blood culture grew TM, confirmed by ITS sequencing(GenBank accession number: PX499650).Despite antifungal therapy, the patient developed severe acute pancreatitis(lipase 1746.9 U/L, > 3 times the upper limit of normal)and multiorgan failure.Extensive investigations excluded common infectious and non-infectious etiologies.The patient died on day 7.This is the first reported case of TM-induced acute pancreatitis likely triggered by fungal microembolization.ConclusionsTM should be considered in HIV patients with unexplained pancreatitis, especially in endemic areas. Peripheral blood smear may serve as a rapid diagnostic clue in disseminated infection,indicating potential organ involvement that may affect uncommon sites.Supplementary informationThe online version contains supplementary material available at 10.1186/s12879-025-12380-6.Keywords: Talaromyces marneffei, Talaromycosis, Acute pancreatitis, Yeast-like fungal structures Background Talaromyces marneffei causes a life-threatening mycosis affecting primarily immunocompromised residents and travellers in southeast Asia, Southern China, and northeastern India [1, 2]. It is a thermally dimorphic fungus that can cause severe infections in epidemic regions of Southeast Asia, particularly in immunocompromised patients [3–5]. It develops into a mycelium at 25 °C and into yeast at 37 °C, but only the yeast-like form has pathogenic potential. Patients with HIV-1/AIDS have been reported to be vulnerable to TM [2, 6, 7]. The intersection with HIV has transformed TM from a rare human pathogen to a major cause of HIV-associated death, second only to tuberculosis and cryptococcosis or Pneumocystis pneumonia in Thailand and Hong Kong [8, 9]. In Vietnam, talaromycosis makes up 4–11% of AIDS-related admissions [10, 11] and is the second most common cause of bloodstream infections after cryptococcosis [12]. Acute pancreatitis is a rare complication of fungal infections. Among reported infectious etiologies, Candida species are most frequently implicated [13]. However, TM-associated pancreatitis has never been documented in the literature. Early recognition is challenging due to nonspecific symptoms and the need to exclude more common etiologies. Case presentation An exceptional case of TM-induced acute pancreatitis in a patient with HIV-1/AIDS is presented. A 52-year-old man,a native of Yuxi County in the Yunnan province of southeast China, was admitted to Yunnan Provincial Hospital of Infectious Disease because of a 15-days history of daily hyperpyrexia and coughing in February 2019. After entering the AIDS phase for more than 5 years, antiviral treatment was started in July, 2014. The protocol was 3TC/AZT/EFV. On July 52,018, HIV-VL was 54000copies/mL, CD4 cell count was 82cells/μL. Due to EFV resistance, the ART protocol was changed to TDF/3TC/LPV/r. The ART drug had been stopped for more than 1 month at admission. CD4 cell count at admission was 134cells/μL. Half a month ago, there was no obvious cause of fever, fever was irregular. The highest body temperature was 39 °C, fearless of cold, shivering, accompanied by paroxysmal cough, expectoration, white sticky sputum, sore throat, aggravated swallowing, night sweats, fatigue, diarrhea, loose stool 3–5 times/day, no mucus, pus and blood. He had been in the local county people’s Hospital, but his condition had not improved. Since the onset of the disease, he had poor mental diet, urinated normally, and lost 5 kg of weight. No previous cholelithiasis, hypertriglyceridemia, diabetes and alcoholism. No abdominal pain, skin lesions, lymphadenopathy, or neurological symptoms were reported at admission, the score of APACHE II was 23. At admission, his white blood cell was 12.4 × 109/L, neutrophil count was 11.11 × 109/L, platelet count was 25 × 109/L (Table S1), serum lactate was 7.92 mmol/L. It was abnormal blood picture. Blood smear reexamination revealed numerous yeast-like fungal structures with sausage-shaped morphology and prominent central septation(Fig. 1B). After empirical antifungal treatment with Fluconazole injection (The timeline was seen in Fig. 1A), there was still fever after empirical antimicrobial therapy with piperacillin/tazobactam. On day 2, antifungal therapy was changed to itraconazole oral solution due to hepatic dysfunction. Despite therapy, inflammatory markers worsened (CRP 213.85 mg/L, PCT 27.88 ng/mL) and thrombocytopenia progressed to 15 × 109/L. On day 3, the patient developed hypotension (BP 98/66 mmHg) and tachypnea (R 32/min), meeting septic shock criteria. Meropenem was added. The patient showed signs of improvement. On the fourth day of admission, the microbiological laboratory reported that filamentous fungi was detected in blood culture (Fig. 2), switch to voriconazole antifungal therapy. In order to further identify the filamentous fungus, the filamentous fungi grown from blood cultures were subcultured on Sabouraud agar at 25 °C and 37°C°C. Molecular identification was performed by amplifying the Internal Transcribed Spacer (ITS) region using primers ITS1 (5’-TCCGTAGGTGAACCTGCGG-3’) and ITS4 (5’-TCCTCCGCTTATTGATATGC-3’) [14]. The obtained 471 bp sequence was deposited in GenBank under accession number PX499650. Phylogenetic analysis using the neighbor-joining method with 1000 bootstrap replications confirmed the isolate as TM with a bootstrap value of 94 (Fig. 3), the conclusion that this strain belongs to TM in the phylogenetic tree is highly credible [15]. The α-amylase was 972.3 U/L (urgent value, Table S2), lipase 1746.9 U/L( > 3 times the upper limit of normal, confirming acute pancreatitis), Triglycerides remained normal (1.93 mmol/L), serum lactate 4.18 mmol/L,K 6.35 mmol/L(urgent value), platelet 18 × 109/L (urgent value), Hemoglobin 48 g/L(urgent value). The patient’s condition worsened further. The trend charts of α-amylase (Fig. 1D,Table S2), platelet count, C-reaction protein concentration, Procalcitonin and Interleukin-6 (Fig. 1C, Table S1) were shown in Fig. 1, Table S1 and Table S2. Abdominal imaging was not obtained due to hemodynamic instability and lack of consent for transport. In addition, nine respiratory tract pathogen tests were negative for adenovirus, influenza A virus IgM antibody, influenza B virus IgM antibody, Mycoplasma pneumoniae IgM antibody, Chlamydia pneumoniae IgM antibody, respiratory syncytial virus IgM antibody, Coxiella burnetii IgM antibody, Legionella pneumophila serogroup 1 IgM antibody, and parainfluenza virus types, and negative for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody, hepatitis E virus antibody, Treponema pallidum antibody, Mycobacterium tuberculosis, Toxoplasma gondii IgM/IgG, cytomegalovirus antibody, and hepatitis A virus antibody. Clinicians considered severe acute pancreatitis, sepsis (Table S3 showed the score of SOFA, Table S4 showed the score of NEWS) combined with multiple organ failure, liver failure, fungemia, severe thrombocytopenia, severe anemia and hyperkalemia. The family members gave up rescue and treatment, and automatically discharged on the sixth day after admission. The patient died after one day of follow-up. Timeline and imaging. (A) Daily clinical course with treatments and vital signs. Antibiotic doses: piperacillin/tazobactam 4.5 g q8h, meropenem 500 mg q12h (renally adjusted), voriconazole 200 mg q12h. (B) Peripheral blood smear (Wright’s stain,×1000) showing intracellular yeast-like fungal structures can be seen under the microscope (cockfighting eyes on both sides of a river). (C) Trend charts of PLT, CRT, PCT and IL-6.(D) Trend chart of α-AMY Talaromyces marneffei culture characteristics. (A) Wine-red colonies after 7 days at 25 °C on Sabouraud agar. (B) Lactophenol cotton blue stain (×1000) showing brush-like penicilli with chains of spherical conidia. (C) White, yeast-like colonies at 37°C. (D) Oval yeast-like cells with central septum (Gram’s stain,×1000) Phylogenetic analysis of Talaromyces marneffei from human in Yunnan, China. The strains we isolated from our patient was marked with a red dot Discussion This patient had a clear history of AIDS and received ART therapy, but the immune reconstitution of the body was poor. Tracing back this patient’s history, he had a long history of irregular use of HAART drugs. Now he had taken the initiative to stop taking the ART drugs, so the immune reconstitution was incomplete, leading to opportunistic infection. In clinical practice, there was very few fungi detected in the blood smear of the patient, but this patient can seen a large number of yeast-like fungal structures in the peripheral blood smear, and show the “cockfighting eyes on both sides of a river” to the extreme. Sepsis caused by a large number of yeast-like fungal structures entering the blood and acute pancreatitis were the major causes of death in this patient. In combination with the previous basic diseases without obvious obstructive diseases of biliary system and hypertriglyceridemia, and under the condition of excluded bilirubin excretion disorder caused by LPV/r in ART drugs, it is considered that AIDS combined with Tararomyces marneffei disseminated sepsis leads to massive pancreatic necrosis and develops into severe acute pancreatitis. Distinguishing TM-induced pancreatitis from drug-related toxicity (particularly protease inhibitors) or opportunistic infections proved difficult. The temporal relationship between fungemia and pancreatic enzyme elevation, exclusion of other causes, support the presumptive diagnosis. The lack of abdominal imaging represents a limitation, preventing confirmation of pancreatic necrosis or fungal abscess formation. Fungal infection [13] is occasionally found among the infectious factors reported in the literature. Candida albicans is the most common in the reports, followed by Candida tropicalis and Candida krusei. However, there have been no reports indicating severe acute pancreatitis with massive pancreatic necrosis caused by disseminated sepsis of TM. The extreme fungal burden evidenced by blood smear positivity suggests a unique pathogenic mechanism warranting further investigation. Organ dysfunction progressed rapidly, with SOFA scores increasing from 6 to 13 (Table S3) and NEWS scores from 7 to 16 (Table S4). Progressive SOFA and NEWS scores objectively quantified multi-organ deterioration. In conclusion, clinicians should strengthen the understanding of talaromycosis and be familiar with its epidemiological characteristics and clinical manifestations. Especially for AIDS patients, it is necessary to carefully ask their medical history and physical examination to broaden the thinking of etiological diagnosis. After admission the score of APACHE II, SOFA, NEWS is very important. At the same time, we should be alert to the occurrence of aucte pancreatitis in AIDS patients with opportunistic infection of TM. This report has several limitations. First, abdominal imaging was not performed,preventing confirmation of pancreatic necrosis or fungal infiltration. Second, exclude other common infectious agents (such as mumps, coxsackievirus, varicella-zoster virus, Salmonella, or Toxoplasma). Third, pancreatic enzyme elevations could partly reflect multiorgan dysfunction rather than isolated pancreatitis. However, the lipase elevation > 3 times the upper limit of normal and temporal association with fungemia strongly support our diagnosis [16]. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Acknowledgements We thank the members of the department of infectious diseases and clinical laboratory in Yunnan Provinical Infectious Diseases Hospital for clinical data and sample collection. We thank the members of the Faculty of Life Science and Technology in Kunming University of Science and Technology for molecular detection and sequence analysis. Abbreviations Talaromyces marneffei Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome Internal Transcribed Spacer Antiretroviral Therapy Highly Active Antiretroviral Therapy Acute Physiology and Chronic Health Evaluation II Sequential Organ Failure Assessment National Early Warning Score Lamivudine Azidothymidine Efavirenz Tenofovir Disoproxil Fumarate Lopinavir/Ritonavir Author contributions Li Gao,Yanqi Peng,Dandan Yang,Sunyun Lei,Mi Zhang, and Xingqi Dong designed the study, analyzed the data, and wrote the manuscript. Yuanlu Shu,Guixian Zhang,Jincheng Lou,Hongli Fan,and Zhenglun Li analyzed the data and reviewed the manuscript. All authors read and approved the final manuscript. Funding This work was supported financially by Yunnan Clinical Research Center for Infectious Disease (AIDS)“Precision oriented research on key technologies of AIDS diagnosis and treatment”(202405AJ310002). Data availability The ITS sequence has been deposited in GenBank under accession number PX499650. Declarations Ethics approval and consent to participate Ethical approval was obtained from the Ethics Committee of Yunnan Provincial Hospital of Infectious Disease (Ref: 201,925), and written informed consent was provided by the patient’s next of kin. Consent for publication Written informed consent was obtained from the patients and his families for publication of this report and any accompanying images. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Yanqi Peng, Mi Zhang and Dandan Yang These authors contributed equally to this work. Contributor Information Suyun Lei, Email: 604308543@qq.com. Xingqi Dong, Email: dongxq8001@126.com. Li Gao, Email: 619082874@qq.com. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement The ITS sequence has been deposited in GenBank under accession number PX499650.